apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Idarubitec 5 Injection 1's

Idarubitec 5 Injection 1's, Pack of 1 INJECTION
Offers on medicine orders
All offers
axis icici
Written By Lakshmithulasi Yarragunta ,
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD

Idarubitec 5 Injection 1's is used to treat cancer. It contains Idarubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis. Thus, Idarubitec 5 Injection 1's stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes cancer cell death. Idarubitec 5 Injection 1's is used in combination with other medicines for the treatment of acute myeloid leukaemia.

Read more
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

IDARUBICIN-5MG

Manufacturer/Marketer :

United Biotech Pvt Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Idarubitec 5 Injection 1's

Idarubitec 5 Injection 1's is an antineoplastic medicine used in the treatment of cancer. Cancer is a disease where the cells grow abnormally and divide uncontrollably. Idarubitec 5 Injection 1's is used in the treatment of Acute Myeloid Leukemia. Leukemia, also known as blood cancer, is the cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections.

Idarubitec 5 Injection 1's contains Idarubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis. Thus, Idarubitec 5 Injection 1's stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes cancer cell death. Idarubitec 5 Injection 1's is used in combination with other medicines for the treatment of acute myeloid leukemia.

Idarubitec 5 Injection 1's may cause certain side effects such as vomiting, nausea, mouth ulcers, loss of appetite, diarrhea, dizziness, weakness, stomach pain, headache, pale skin, difficulty urinating, fever, and pain at the site of injection. Most of these side effects of Idarubitec 5 Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Idarubitec 5 Injection 1's is a parenteral preparation and will be administered by the oncology doctor. Hence, do not self-administer. Your doctor will decide the dose of the medicine based on the severity of the condition.

Idarubitec 5 Injection 1's should be avoided if you are allergic to it or any other component present in it. Inform your doctor about your complete medical and medication history before starting treatment with Idarubitec 5 Injection 1's. Idarubitec 5 Injection 1's is contraindicated for pregnant women due to serious embryo-fetal toxicity. Inform your doctor if you are pregnant, planning to become pregnant or breastfeeding. Inform your doctor if you have /had any pre-existing liver or kidney disease, bone marrow suppression, or heart disease, as it may cause serious adverse effects or worsen the condition. Avoid alcohol consumption with Idarubitec 5 Injection 1's as it may increase the risk of liver damage. This medicine is not recommended for children as safety and efficacy are not established.

Uses of Idarubitec 5 Injection 1's

Idarubitec 5 Injection 1's is used in the treatment of acute myeloid leukemia (AML). The detailed uses of Idarubitec 5 Injection 1's are as follows:<br/>• Treatment of acute myeloid leukemia (AML): Idarubitec 5 Injection 1's is used in combination with other medications to treat acute myelogenous leukemia, a cancer of the white blood cells.<br/>• Inhibits cancer cell growth: Idarubitec 5 Injection 1's belongs to the anthracycline class of drugs and works by slowing or stopping the growth of cancer cells in the body.<br/>

Directions for Use

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.• Idarubitec 5 Injection 1's will be administered by the doctor or healthcare professional.• Do not self-administer.

Medicinal Benefits

Idarubitec 5 Injection 1's contains Idarubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis. Thus, Idarubitec 5 Injection 1's stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes cancer cell death.

How Idarubitec 5 Injection 1's Works

Idarubitec 5 Injection 1's contains Idarubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis. Thus, Idarubitec 5 Injection 1's stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes cancer cell death. Idarubitec 5 Injection 1's is used in combination with other medicines for the treatment of acute myeloid leukemia.

Storage

• Store in a cool and dry place away from sunlight.• Keep Idarubitec 5 Injection 1's out of the sight and reach of children. • Cold chain - To be stored in cold places at 2ºC to 8ºC.

What if I have taken an overdose of Idarubitec 5 Injection 1's

As Idarubitec 5 Injection 1's is a parenteral formulation administered by experienced medical staff, the chance of overdose may be less. However, if you think there has been an overdose or experiencing any adverse events, get medical care right away. Overdose of Idarubitec 5 Injection 1's may cause nausea, vomiting, severe stomach pain, sores in the mouth and throat, unusual bleeding or bruising, fever, sore throat, chills, or other signs of infection, black and tarry stools, and red blood in stools.

Drug Warnings

Idarubitec 5 Injection 1's should be avoided if you are allergic to it or any other component present in it. Inform your doctor about your complete medical and medication history before starting treatment with Idarubitec 5 Injection 1's. Idarubitec 5 Injection 1's is contraindicated for pregnant women and breastfeeding women due to serious embryo-fetal toxicity. Inform your doctor if you are pregnant, planning to become pregnant or breastfeeding. Inform your doctor if you have /had any pre-existing liver or kidney disease, pre-existing bone marrow suppression, or pre-existing heart disease, as it may cause serious adverse effects or worsen the condition. Avoid alcohol consumption with Idarubitec 5 Injection 1's as it may increase the risk of liver damage. This medicine is not recommended for children as safety and efficacy are not established.

Diet & Lifestyle Advise

  • Maintain a balanced diet including fruits and vegetables rich in nutrients and low-fat proteins like lean meats, fish and poultry.
  • Drink plenty of water daily while taking Idarubitec 5 Injection 1's as some cancer therapies may cause dehydration.
  • Exercise regularly and maintain a healthy body weight.
  • Regularly wash your hands and avoid contact with people having infections.
  • Quit smoking and alcohol consumption.

Habit Forming

No

Therapeutic Class

ANTINEOPLASTIC

Idarubitec 5 Injection 1's Substitute

Substitutes safety advice

Product Substitutes

bannner image

Alcohol

Unsafe

Avoid consumption of alcohol with Idarubitec 5 Injection 1's as it may increase the risk of liver damage.

bannner image

Pregnancy

Unsafe

It is not recommended for use in pregnancy as it may harm your foetus. If you are pregnant or planning pregnancy, inform your doctor before receiving Idarubitec 5 Injection 1's. Use effective contraception to avoid pregnancy while on treatment with this medicine.

bannner image

Breast Feeding

Unsafe

It is not recommended for use in breastfeeding as it may pass into breast milk and harm your infant. Because of the possibility of major adverse events in nursing infants from the medicine, women should quit nursing prior to taking the drug and refrain from breastfeeding during treatment and for 14 days after the final dosage.

bannner image

Driving

Unsafe

Idarubitec 5 Injection 1's causes dizziness and may alter the ability to drive or operate machines. Hence, avoid driving or operating machines after taking Idarubitec 5 Injection 1's.

bannner image

Liver

Caution

If you have a pre-existing or a history of liver disease, inform your doctor before receiving Idarubitec 5 Injection 1's. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Your doctor may also suggest liver function tests while on treatment with Idarubitec 5 Injection 1's.

bannner image

Kidney

Caution

If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Idarubitec 5 Injection 1's. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition. Your doctor may also suggest renal function tests while on treatment with Idarubitec 5 Injection 1's.

bannner image

Children

Unsafe

Idarubitec 5 Injection 1's is not recommended for use in children as the safety and efficacy have not been established.

Have a query?

FAQs

Idarubitec 5 Injection 1's is used to treat Acute Myeloid Leukemia.

Idarubitec 5 Injection 1's contains Idarubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, destroying DNA and RNA synthesis.

If you are about to receive any vaccinations, especially live vaccines such as measles, mumps, rubella and polio vaccines, it is advised to inform your doctor that you are on treatment with Idarubitec 5 Injection 1's as it may cause infections.

Yes, Idarubitec 5 Injection 1's is a vesicant. Vesicants are drugs that can cause severe tissue damage and blistering if they leak out of the vein during administration (a process known as extravasation). Always ensure Idarubitec 5 Injection 1's should be administered by trained healthcare professionals to minimize risks.

The side effects of Idarubitec 5 Injection 1's include nausea, vomiting, mouth ulcers, loss of appetite, diarrhoea, dizziness, weakness, stomach pain, headache, pale skin, difficulty urinating, fever, and pain at the injection site. Consult the doctor if any of these symptoms persist or worsen.

Country of origin

India

Manufacturer/Marketer address

Fc/B-1 (Extn.), Mohan Co-Operative Industrial Estate Mathura Road, New Delhi - 110 044.
Other Info - IDA0018

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Author Details

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 18, 2025 | 6:20 PM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050734s027lbl.pdf
  2. https://medlineplus.gov/druginfo/meds/a691004.html
  3. https://reference.medscape.com/drug/idarubicin-342123
  4. https://go.drugbank.com/drugs/DB01177

Buy best Neoplastic Disorders products by

whatsapp Floating Button
Buy Now
Add to Cart